The impact of cardiovascular risk factors in non-classical Fabry disease. [PDF]
Orphanet J Rare DisVeldman BCF +9 more
europepmc +1 more source
Tolerability of SGLT2 inhibitors in patients with Fabry disease: An observational study. [PDF]
Am Heart J PlusMattig I +7 more
europepmc +1 more source
Patient-Centric Approach to Improve the Quality of Life and Healing Efficacy for Patients With Fabry Disease: A Grounded Theory-Based Analysis. [PDF]
J Korean Med SciGwak SY +7 more
europepmc +1 more source
Sex-Based Disparities in Fabry Disease Cause Challenges in Newborn Screening.
Public Health GenomicsFuruta Y +12 more
europepmc +1 more source
Impact of migalastat therapy on corneal deposits in a female with Fabry disease: A case report. [PDF]
Mol Genet Metab RepVitturi N +5 more
europepmc +1 more source
The Sphingolipid Balance and Endothelial Dysfunction in Lysosomal Storage Diseases: Shared Mechanisms in Gaucher, Niemann-Pick and Fabry Disease. [PDF]
Int J Mol SciNekrasova A, Kutsev S, Shestopalov A.
europepmc +1 more source
Development and validation of a self-management efficacy questionnaire for patients with Fabry disease in China. [PDF]
Ann MedCao ML +6 more
europepmc +1 more source
Clinical outcomes of agalsidase Beta (fabrazyme) in Chinese fabry disease patients with proteinuria: a case series. [PDF]
Front PediatrHe Z, Wu Y, Yang H, Li Y, Xu L.
europepmc +1 more source
A new approach methodology for studying intrinsic ventricular arrhythmias in Fabry disease. [PDF]
Front Cardiovasc MedMonteiro da Rocha A +6 more
europepmc +1 more source